US-Cuba thaw may yield cancer drugs

• Autores: Will Grant
• Localización: New scientist, ISSN 0262-4079, Nº. 3039, 2015, pág. 10
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Cuban researchers are helping lead the fight against lung cancer. They recently added a new weapon to the arsenal against lung cancer: Cimavax. This vaccine--designed to be given to people with cancer--encourages the immune system to attack a protein that fuels tumor growth, slowing the disease's spread. The basic idea is to mobilize the immune system so the components which typically defend you are able to fight the cancer cells growing inside the body, says Kaleb Leon, director of investigation and research at the Center of Molecular Immunology in Havana, where the drug was developed. Here, Grant discusses how US-Cuba thaw could bring important gains for cancer research